STAAR Surgical Company (STAA) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
18 Jun, 2026Opening remarks and agenda
The meeting was called to order at 8:30 A.M. Pacific Time, with board members and executive leadership present.
The agenda and rules of conduct were posted online and accessible via the virtual portal.
The meeting was convened pursuant to a formal notice dated May 4, 2026.
Board and executive committee updates
Board members and key executives, including interim Co-CEOs and the CFO, were introduced.
The Secretary and Inspector of Elections were designated for the meeting.
Shareholder proposals
Four proposals were presented: election of seven directors, amendment to the equity incentive plan, ratification of BDO as auditors, and advisory approval of executive compensation.
The board recommended voting in favor of all proposals.
Partial view of Summaries dataset, powered by Quartr API
Latest events from STAAR Surgical Company
- China-led growth, Swiss supply expansion and a renewed innovation pipeline shape the strategy.STAA
Canaccord Genuity's MedTech, Diagnostics and Digital Health & Services Forum - China growth, improving supply and richer product mix underpin the near-term outlook.STAA
Stifel 2026 Healthcare Conference 2026 - Record 9M results and Q3 underlying growth offset temporary margin and supply pressures.STAA
Q3 2026 - Q2 2026 net sales rose 111% year-over-year, led by China, with strong profit and margin gains.STAA
Q2 2026 - Strong Q1 growth in China and the U.S. driven by EVO+ demand and targeted marketing.STAA
Status update - China stabilizes, global growth continues, and innovation plus efficiency drive future margins.STAA
Stifel 2026 Virtual Ophthalmology Forum - Record Q1 sales and profitability driven by China and U.S. growth, with margin expansion.STAA
Q1 2026 - Leadership changes, strategic reset, and key governance votes define the 2026 proxy.STAA
Proxy filing - 2024 net loss driven by China slump, but ex-China ICL sales grew 13% and global demand is strong.STAA
Q4 2024